D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CDNA holding history
CareDx, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CDNA overviewAll 13F holders of CDNAFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,137,660
- Value
- $32.4M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,137,660 | $32.4M | <0.1% | +262,752+30.0% | Added | Holders |
| Q1 2026 | 874,908 | $15.2M | <0.1% | −163,578−15.8% | Reduced | Holders |
| Q4 2025 | 1,038,486 | $19.6M | <0.1% | +443,995+74.7% | Added | Holders |
| Q3 2025 | 594,491 | $8.64M | <0.1% | −20,883−3.4% | Reduced | Holders |
| Q2 2025 | 615,374 | $12.0M | <0.1% | −167,639−21.4% | Reduced | Holders |
| Q1 2025 | 783,013 | $13.9M | <0.1% | −366,215−31.9% | Reduced | Holders |
| Q4 2024 | 1,149,228 | $24.6M | <0.1% | −210,999−15.5% | Reduced | Holders |
| Q3 2024 | 1,360,227 | $42.5M | 0.1% | −367,663−21.3% | Reduced | Holders |
| Q2 2024 | 1,727,890 | $26.8M | <0.1% | −294,244−14.6% | Reduced | Holders |
| Q1 2024 | 2,022,134 | $21.4M | <0.1% | −179,087−8.1% | Reduced | Holders |
| Q4 2023 | 2,201,221 | $26.4M | <0.1% | −123,211−5.3% | Reduced | Holders |
| Q3 2023 | 2,324,432 | $16.3M | <0.1% | −111,321−4.6% | Reduced | Holders |
| Q2 2023 | 2,435,753 | $20.7M | <0.1% | +401,225+19.7% | Added | Holders |
| Q1 2023 | 2,034,528 | $18.6M | <0.1% | +628,715+44.7% | Added | Holders |
| Q4 2022 | 1,405,813 | $16.0M | <0.1% | +530,583+60.6% | Added | Holders |
| Q3 2022 | 875,230 | $14.9M | <0.1% | +389,618+80.2% | Added | Holders |
| Q2 2022 | 485,612 | $10.4M | <0.1% | +164,129+51.1% | Added | Holders |
| Q1 2022 | 321,483 | $11.9M | <0.1% | −147,684−31.5% | Reduced | Holders |
| Q4 2021 | 469,167 | $21.3M | <0.1% | −346,998−42.5% | Reduced | Holders |
| Q3 2021 | 816,165 | $51.7M | 0.1% | −97,462−10.7% | Reduced | Holders |
| Q2 2021 | 913,627 | $83.6M | 0.1% | −302,304−24.9% | Reduced | Holders |
| Q1 2021 | 1,215,931 | $82.8M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.